TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/14/2024
Back to search
Official data from USPTO
BIGFOOT BIOMEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
05/14/2024
Trademark type
Combined
Nice classes
9, 10, 39
Filing date
04/30/2018
Registration date
03/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/01/2022
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/28/2021
First use in commerce
07/09/2021
Drawing code
3
Owner type
03
Owner location
Milpitas, CA, US
Examiner
PERRY, KIMBERLY
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "bigfoot biomedical" with "bigfoot" appearing in larger letters above "biomedical" and two eyes formed from the letters "o" with a unibrow positioned above the eyes and the pupils looking to the left.
Holders and representatives
Holders
Bigfoot Biomedical, Inc.
Representatives
Michele H. Bowman Abbott Laboratories
Technical classification
Nice Classes
Class 9Class 10Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software application for mobile phones or tablet computerssoftware for use in the management of diabetes using data from blood glucose meters and insulin delivery devices includingsoftware for capturingmeasuringmonitoringtracking blood glucoseproviding recommendations for insulin dosage requirements; computer software for collectiontransmissiondisplay of medical data for management of diabetes and delivery of diabetic supplies
Class 10
Medical devices for use in managing diabetesreplacement caps for insulin injection devices capable of capturingmeasuringmonitoring insulin dosage amounts; blood glucose meters
Class 39
Distribution servicesdelivery of supplies for management of diabetes
Publications
History of USPTO decisions and trademark events.
49 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/14/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/14/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/14/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/14/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/28/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/27/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/22/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/21/2021
EX5G
SOU EXTENSION 5 GRANTED
12/21/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/21/2021
IUAF
USE AMENDMENT FILED
12/13/2021
EXT5
SOU EXTENSION 5 FILED
12/13/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/13/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/13/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/09/2021
EX4G
SOU EXTENSION 4 GRANTED
06/07/2021
EXT4
SOU EXTENSION 4 FILED
06/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/19/2020
EX3G
SOU EXTENSION 3 GRANTED
11/17/2020
EXT3
SOU EXTENSION 3 FILED
11/17/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/17/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/11/2020
EX2G
SOU EXTENSION 2 GRANTED
06/09/2020
EXT2
SOU EXTENSION 2 FILED
06/09/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2019
EX1G
SOU EXTENSION 1 GRANTED
12/06/2019
EXT1
SOU EXTENSION 1 FILED
12/06/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/06/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBO
PUBLISHED FOR OPPOSITION
04/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/12/2019
ALIE
ASSIGNED TO LIE
03/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/15/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/27/2018
GNRT
NON-FINAL ACTION E-MAILED
08/27/2018
CNRT
NON-FINAL ACTION WRITTEN
08/27/2018
DOCK
ASSIGNED TO EXAMINER
08/21/2018
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2018
NWAP
NEW APPLICATION ENTERED
05/03/2018
Continuous trademark protection
Get notified about every new filing that threatens BIGFOOT BIOMEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.